Literature DB >> 19549579

Infections in patients with aplastic anemia.

Jessica M Valdez1, Phillip Scheinberg, Neal S Young, Thomas J Walsh.   

Abstract

Infection is a major cause of death in patients with aplastic anemia (AA). There are differences between the immunocompromised state of a patient with AA and the patient who is neutropenic due to chemotherapy and this leads to a difference in the infections that they incur. Prolonged neutropenia is one of the largest risk factors for the development of infections with the invasive mycoses and bacteria. Recovery from neutropenia is directly related to survival, and supportive care plays a large role in protection while the patient is in a neutropenic state. The most common invasive mycoses include the Aspergillus species, Zygomycetes, Candida spp., and Fusarium spp. Bacterial infections that are seen in patients with AA include gram-positive coagulase-negative Staphylococcus species, Enterococcus, Staphylococus aureus, Clostridium spp., Micrococcus, alpha-hemolytic streptococci, Listeria monocytogenes, and Bacillus cereus. Gram-negative infections including gram-negative bacilli, Escherichia coli, Salmonella, Bacteroides fragilis, Klebsiella oxytoca, Klebsiella pneumonia, Aeromonas hydrophilia, Pseudomonas aeruginosa, and Vibrio vulnificus. Viral infections are much less common but include those that belong to the Herpesviridae family, community-acquired respiratory viral infection, and the viral hepatitides A, B, and C. Evidence of the parasite Strongyloides stercoralis has also been documented. This review discusses the major invasive fungal infections, bacterial pathogens, parasites, and viral infections that are found in patients with AA who are treated with immunosuppressive therapy. The specific immune impairment and current treatment parameters for each of these classes of infection will also be discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19549579     DOI: 10.1053/j.seminhematol.2009.03.008

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  30 in total

Review 1.  Recognition and prevention of hospital-associated enteric infections in the intensive care unit.

Authors:  Linda D Bobo; Erik R Dubberke
Journal:  Crit Care Med       Date:  2010-08       Impact factor: 7.598

Review 2.  Clinical management of aplastic anemia.

Authors:  Amy E Dezern; Robert A Brodsky
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

3.  Colon cancer in a patient with underlying aplastic anemia: A clinical challenge.

Authors:  Hilda Wong; Pierre Chan; Thomas Yau
Journal:  World J Clin Oncol       Date:  2012-02-10

4.  Combination Therapy with Isavuconazole and Micafungin for Treatment of Experimental Invasive Pulmonary Aspergillosis.

Authors:  Vidmantas Petraitis; Ruta Petraitiene; Matthew W McCarthy; Laura L Kovanda; Myo H Zaw; Kaiser Hussain; Naima Shaikh; Bo Bo W Maung; Navjot K Sekhon; William W Hope; Thomas J Walsh
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

5.  Neutrophil and endothelial adhesive function during human fetal ontogeny.

Authors:  Claudia Nussbaum; Anna Gloning; Monika Pruenster; David Frommhold; Susanne Bierschenk; Orsolya Genzel-Boroviczény; Ulrich H von Andrian; Elizabeth Quackenbush; Markus Sperandio
Journal:  J Leukoc Biol       Date:  2012-12-11       Impact factor: 4.962

6.  Hepatitis-associated aplastic anaemia: a poor prognosis.

Authors:  Vivian Gonçalves; Rita Calado; Maria João Palaré; Anabela Ferrão; Anabela Morais
Journal:  BMJ Case Rep       Date:  2013-02-13

7.  Diagnosis and treatment of pediatric acquired aplastic anemia (AAA): an initial survey of the North American Pediatric Aplastic Anemia Consortium (NAPAAC).

Authors:  David A Williams; Carolyn Bennett; Alison Bertuch; Monica Bessler; Thomas Coates; Seth Corey; Yigal Dror; James Huang; Jeffrey Lipton; Timothy S Olson; Ulrike M Reiss; Zora R Rogers; Colin Sieff; Adrianna Vlachos; Kelly Walkovich; Winfred Wang; Akiko Shimamura
Journal:  Pediatr Blood Cancer       Date:  2013-11-27       Impact factor: 3.167

8.  Lipocalin 2 is protective against E. coli pneumonia.

Authors:  Hong Wu; Eric Santoni-Rugiu; Elisabeth Ralfkiaer; Bo T Porse; Claus Moser; Niels Høiby; Niels Borregaard; Jack B Cowland
Journal:  Respir Res       Date:  2010-07-15

9.  High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia.

Authors:  Christopher J Gamper; Clifford M Takemoto; Allen R Chen; Heather J Symons; David M Loeb; James F Casella; Amy E Dezern; Karen E King; Andrea M McGonigle; Richard J Jones; Robert A Brodsky
Journal:  J Pediatr Hematol Oncol       Date:  2016-11       Impact factor: 1.289

Review 10.  Aplastic anemia: pathophysiology and treatment.

Authors:  Neal S Young; Andrea Bacigalupo; Judith C W Marsh
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-24       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.